AlphaCore Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.8M Buy
50,226
+17,289
+52% +$4.03M 0.23% 93
2026
Q1
$8.05M Sell
32,937
-6,268
-16% -$1.46M 0.19% 100
2025
Q4
$8.11M Buy
39,205
+7,357
+23% +$1.45M 0.18% 110
2025
Q3
$5.91M Buy
31,848
+5,343
+20% +$915K 0.2% 99
2025
Q2
$4.05M Buy
26,505
+5,686
+27% +$874K 0.15% 118
2025
Q1
$3.45M Buy
20,819
+9,650
+86% +$1.51M 0.29% 74
2024
Q4
$1.62M Sell
11,169
-218
-2% -$33.8K 0.35% 52
2024
Q3
$1.85M Sell
11,387
-320
-3% -$51K 0.42% 45
2024
Q2
$1.71M Sell
11,707
-1,317
-10% -$196K 0.41% 42
2024
Q1
$2.06M Sell
13,024
-41
-0.3% -$6.53K 0.55% 34
2023
Q4
$2.05M Sell
13,065
-125
-0.9% -$19.2K 0.3% 59
2023
Q3
$2.05M Buy
13,190
+488
+4% +$80.5K 0.32% 58
2023
Q2
$2.1M Buy
12,702
+1,658
+15% +$268K 0.34% 60
2023
Q1
$1.71M Buy
11,044
+2,854
+35% +$461K 0.45% 36
2022
Q4
$1.45M Buy
8,190
+1,083
+15% +$187K 0.56% 22
2022
Q3
$1.16M Buy
7,107
+1,253
+21% +$212K 0.53% 23
2022
Q2
$1.04M Buy
5,854
+443
+8% +$78.9K 0.48% 22
2022
Q1
$959K Buy
5,411
+4,015
+288% +$683K 0.37% 26
2021
Q4
$239K Sell
1,396
-109
-7% -$17.8K 0.1% 44
2021
Q3
$243K Buy
+1,505
New +$257K 0.12% 47
2020
Q3
Sell
-617
Closed -$87K 68
2020
Q2
$87K Sell
617
-260
-30% -$37.9K 0.09% 41
2020
Q1
$115K Buy
+877
New +$124K 0.09% 67

Other funds holding JNJ

AlphaCore Capital's JNJ Position: Q2 2026 in Review

AlphaCore Capital increased its Johnson & Johnson (JNJ) stake by 52% in Q2 2026, buying an estimated $4.03M and bringing the position to 50,226 shares worth $12.8M. The position accounts for 0.23% of the portfolio, ranked #93.

AlphaCore Capital first reported a position in JNJ in Q1 2020 and has held it in 22 quarters since. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • AlphaCore Capital held 50,226 shares of Johnson & Johnson worth $12.8M as of Q2 2026.
  • AlphaCore Capital bought 17,289 Johnson & Johnson shares in Q2 2026, an estimated $4.03M.
  • Johnson & Johnson made up 0.23% of AlphaCore Capital's portfolio in Q2 2026, its #93 holding.
  • AlphaCore Capital first reported a position in Johnson & Johnson in Q1 2020 and has held it in 22 quarters since.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.